Oxana Schmidt
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 04, 2022
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 10, 2021
Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma.
Journal: Cancers
Published: December 17, 2019
Matrix mineralization controls gene expression in osteoblastic cells.
Journal: Experimental cell research
Published: May 17, 2018
Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.
Journal: Oncoimmunology
Published: January 23, 2017
The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
Journal: Molecular oncology
Published: December 21, 2015
The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
Journal: Oncotarget
Published: December 02, 2015
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.
Journal: Oncoimmunology
Published: November 17, 2015
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Journal: Oncotarget
Published: September 11, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026